title: Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.
abstract: Mitotic regulator genes have been associated with several cancers, however little is known about their possible association with pancreatic cancer. Smoking and family history are the strongest risk factors for this highly fatal disease. The main purpose of this study was to determine if polymorphisms of mitotic regulator genes are associated with pancreatic cancer and whether they modify the association between cigarette smoking and pancreatic cancer risk. A population-based case-control study was conducted in Ontario with 455 pathology-confirmed pancreatic cancer cases and 893 controls. Cigarette smoking history was collected using questionnaires and DNA obtained from blood samples. Genotypes were determined by mass-spectrometry. Odds ratio estimates were obtained using multivariate logistic regression. Interactions between genetic variant and smoking were assessed using stratified analyses and the likelihood ratio statistic (significance P < 0.05). Variants of MCPH1, FYN, APC, PRKCA, NIN, TopBP1, RIPK1, and SNW1 were not independently associated with pancreatic cancer risk. A significant interaction was observed between pack-years and MCPH1-2550-C > T (P = 0.02). Compared to never smokers, individuals with 10-27 pack-years and MCPH1-2550-CC genotype were at increased risk for pancreatic cancer (MVOR = 2.49, 95% confidence interval [95% CI]: 1.55, 4.00) as were those with >27 pack-years and MCPH1-2550-TC genotype (MVOR = 2.42, 95% CI: 1.45, 4.05). A significant interaction was observed between smoking status and TopBP1-3257-A > G (P = 0.04) using a dominant model. Current smokers with the TopBP1-3257 A allele were at increased risk for pancreatic cancer (MVOR = 2.55, 95% CI: 1.77, 3.67). MCPH1-2550-C > T and TopBP1-3257-A > G modify the association between smoking and pancreatic cancer. These findings provide insights into the potential molecular mechanisms behind smoking-associated pancreatic cancer.
authors.affiliation: Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Prevention and Cancer Control, Cancer Care Ontario, Toronto, Ontario, Canada.
authors.forename: Ji-Hyun
authors.initials: JH
authors.lastname: Jang
authors.forename: Michelle
authors.initials: M
authors.lastname: Cotterchio
authors.forename: Ayelet
authors.initials: A
authors.lastname: Borgida
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Liu
authors.forename: Steven
authors.initials: S
authors.lastname: Gallinger
authors.forename: Sean P
authors.initials: SP
authors.lastname: Cleary
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D008938:Mitosis / Q000235:genetics*; D009367:Neoplasm Staging; D016017:Odds Ratio; D010190:Pancreatic Neoplasms / Q000209:etiology* / Q000473:pathology; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000235:genetics*; D011379:Prognosis; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor
keywords: case-control studies; mitosis; pancreatic neoplasms; polymorphism, single nucleotide; smoking
references.citation: Chronic Dis Can. 2000;21(2):81-6
references.pmid: 11007659
references.citation: Mol Cell Biol. 2009 May;29(10):2673-93
references.pmid: 19289498
references.citation: Carcinogenesis. 2007 May;28(5):899-912
references.pmid: 17259655
references.citation: Cancer Causes Control. 2009 Aug;20(6):825-34
references.pmid: 19194662
references.citation: EMBO J. 2010 Nov 3;29(21):3723-32
references.pmid: 20871591
references.citation: Breast Cancer Res Treat. 2010 Jan;119(2):453-62
references.pmid: 19404734
references.citation: Am J Public Health. 1989 Mar;79(3):340-9
references.pmid: 2916724
references.citation: J Cancer Res Clin Oncol. 2011 Apr;137(4):705-13
references.pmid: 20567846
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43
references.pmid: 17982118
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):704-10
references.pmid: 16614112
references.citation: Cancer Res. 2003 Jun 15;63(12):3049-53
references.pmid: 12810625
references.citation: Int J Cancer. 2007 Nov 15;121(10):2241-5
references.pmid: 17582608
references.citation: Carcinogenesis. 2012 Apr;33(4):818-27
references.pmid: 22301281
references.citation: Clin Transl Oncol. 2006 Jun;8(6):399-408
references.pmid: 16790392
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):251-7
references.pmid: 20056645
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15105-9
references.pmid: 16217032
references.citation: Am J Hum Genet. 1999 Feb;64(2):378-84
references.pmid: 9973276
references.citation: Br J Cancer. 2011 May 10;104(10):1602-10
references.pmid: 21505456
references.citation: J Biol Chem. 2004 Aug 13;279(33):34091-4
references.pmid: 15220350
references.citation: Eur J Cancer. 2006 Oct;42(15):2647-52
references.pmid: 16930991
references.citation: Tumori. 2010 Nov-Dec;96(6):1004-9
references.pmid: 21388066
references.citation: Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1864-8
references.pmid: 19454617